Goodwin advised ReViral on the deal. Clifford Chance advised Pfizer.ReViral announced its acquisition by Pfizer. Pfizer will acquire ReViral for a total consideration of up to $525…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
